Plexus (NASDAQ:PLXS – Get Free Report) had its price objective boosted by stock analysts at Needham & Company LLC from $206.00 to $285.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the technology company’s stock. Needham & Company LLC’s price target suggests a potential upside of 13.74% from the company’s previous close.
Several other research firms also recently commented on PLXS. Wall Street Zen downgraded shares of Plexus from a “buy” rating to a “hold” rating in a research report on Sunday, March 8th. Williams Trading set a $195.00 price target on shares of Plexus in a research report on Wednesday, January 28th. Benchmark reiterated a “buy” rating and issued a $220.00 price target on shares of Plexus in a research report on Monday, March 16th. Raymond James Financial reiterated an “outperform” rating and issued a $275.00 price target on shares of Plexus in a research report on Thursday. Finally, Weiss Ratings downgraded shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, April 24th. Five equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $229.17.
Check Out Our Latest Analysis on Plexus
Plexus Stock Down 0.0%
Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, beating the consensus estimate of $1.87 by $0.18. Plexus had a net margin of 4.35% and a return on equity of 12.92%. The firm had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.13 billion. During the same quarter in the prior year, the firm earned $1.66 EPS. Plexus’s revenue for the quarter was up 18.7% on a year-over-year basis. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Sell-side analysts expect that Plexus will post 6.56 earnings per share for the current year.
Insider Activity at Plexus
In other Plexus news, COO Oliver K. Mihm sold 9,541 shares of the company’s stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $201.40, for a total transaction of $1,921,557.40. Following the completion of the transaction, the chief operating officer owned 12,809 shares in the company, valued at approximately $2,579,732.60. This represents a 42.69% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Todd P. Kelsey sold 8,120 shares of the company’s stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $205.65, for a total transaction of $1,669,878.00. Following the transaction, the chief executive officer owned 78,598 shares of the company’s stock, valued at approximately $16,163,678.70. The trade was a 9.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 50,995 shares of company stock worth $10,345,971 in the last 90 days. Corporate insiders own 1.78% of the company’s stock.
Hedge Funds Weigh In On Plexus
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Sage Rhino Capital LLC acquired a new position in shares of Plexus during the 1st quarter worth $214,000. Abel Hall LLC grew its stake in shares of Plexus by 51.4% during the 1st quarter. Abel Hall LLC now owns 2,321 shares of the technology company’s stock worth $470,000 after purchasing an additional 788 shares during the period. DGS Capital Management LLC acquired a new position in shares of Plexus during the 1st quarter worth $235,000. QRG Capital Management Inc. grew its stake in shares of Plexus by 15.8% during the 1st quarter. QRG Capital Management Inc. now owns 3,265 shares of the technology company’s stock worth $661,000 after purchasing an additional 445 shares during the period. Finally, Elevation Point Wealth Partners LLC acquired a new position in shares of Plexus during the 1st quarter worth $457,000. 94.45% of the stock is owned by institutional investors and hedge funds.
Key Plexus News
Here are the key news stories impacting Plexus this week:
- Positive Sentiment: Raised guidance: Plexus updated FYQ3 EPS guidance to $2.02–$2.18 (consensus ~$1.93) and revenue guidance to $1.2B–$1.3B (vs. ~$1.1B consensus), a clear indicator management expects continued demand and margin expansion. Guidance & Slide Deck
- Positive Sentiment: Revenue beat / strong growth: Plexus reported record Q2 revenue (~$1.164B), up ~18.7% year‑over‑year and modestly above Street revenue expectations — evidence of strong program wins and end‑market demand. Earnings Release
- Positive Sentiment: Analyst sentiment supportive: Recent analyst coverage averages a “Moderate Buy” and several firms maintain buy ratings and targets above current levels, which can support near‑term buying interest. Analyst Rating Article
- Positive Sentiment: ETF/index fund chatter: Coverage highlights that Plexus’ strong quarter has prompted talk about index/ETF reweighting on Nasdaq funds — potential incremental demand if funds increase allocations. Index Fund Buzz
- Neutral Sentiment: CFO transition announced: CFO Patrick Jermain — a 12‑year CFO — will retire; management says succession is planned. Leadership change is notable but presented as orderly. CFO Transition Release
- Neutral Sentiment: Earnings materials and call available: Full earnings deck and multiple call transcripts/slides released — useful for digging into segment trends, backlog and customer commentary. Earnings Presentation
- Negative Sentiment: Mixed EPS reporting / earnings surprise nuance: Some outlets report a GAAP/non‑GAAP EPS beat (reports showing $2.05) while other disclosures show diluted EPS of $1.82 vs. some Street estimates ~ $1.90–$1.92 — the mismatch created intraday volatility as investors parsed which metric to use. Quiver Quant Earnings Summary
- Negative Sentiment: Cash flow and balance-sheet flags: Operating cash flow declined (~22% YoY) and cash modestly fell while total liabilities rose — investors will watch free cash flow and working capital conversion in coming quarters. Financial Details
- Negative Sentiment: Insider selling noted: Filings show multiple insider sales over the past months; heavy insider selling can weigh on sentiment even if sales are for routine/estate reasons. Insider Activity
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Further Reading
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
